A. Leigh Corbett
$300M Loan; FDA Progress for 2020
Urovant Sciences Ltd. (Nasdaq: UROV), which is developing medications to treat urologic issues, is starting the year with a new main investor from Japan, a $300 million loan, and progress in getting its core drug, vibegron, to market in the U.S.
HEALTHCARE: Irvine opening expected in ’21
Cancer treatment plans went big in Orange County in 2019—witness Mission Hospital’s November unveiling of its new Judi and Bill Leonard Institute for Cancer Prevention, Treatment and Wellness in Mission Viejo, and the $120 million in funding now raised by Irvine’s Laboratory for Advanced Medicine, a 5-year-old firm that uses artificial intelligence to identify early stages of specific cancers.
First Such Artery Imaging Device for Japan
Aliso Viejo-based CathWorks, a medical device maker that provides 3D imaging of the coronary artery branch, announced in December the approval of its FFRangio system by Japan’s Ministry of Health, Labour and Welfare.
Still Faces Medtronic Infringement Charges
Irvine-based device maker Axonics Modulation Technologies Inc. (Nasdaq: AXNX) won nine new patents pertaining to its main electrostimulation product, at the same time it’s being sued by Medtronic PLC for patent infringement.
Cancer Treatment, Legal Issues at Forefront
2018 was the Year of the IPO for OC’s healthcare scene, with a quartet of drugmakers, device makers and medical aesthetics firms joining the ranks of the publicly traded.